New lead for potential Parkinson’s treatment: Effects of high-risk Parkinson’s mutation are reversible

Researchers from the University of Sheffield, and members of the Centre for Membrane Interactions and Dynamics (CMIAD), have found vital new evidence on how to target and reverse the effects caused by one of the most common genetic causes of Parkinson’s.

The team, led by Parkinson’s UK funded researchers Dr Kurt De Vos from the Department of Neuroscience and Dr Alex Whitworth from the Department of Biomedical Sciences, found that certain drugs could fully restore movement problems observed in fruit flies carrying the LRRK2 Roc-COR Parkinson’s mutation.

Read more at the University Media Centre